TY  - JOUR
AU  - Lazarus, Jeffrey V
AU  - Mark, Henry E
AU  - Anstee, Quentin M
AU  - Arab, Juan Pablo
AU  - Batterham, Rachel L
AU  - Castera, Laurent
AU  - Cortez-Pinto, Helena
AU  - Crespo, Javier
AU  - Cusi, Kenneth
AU  - Dirac, M Ashworth
AU  - Francque, Sven
AU  - George, Jacob
AU  - Hagström, Hannes
AU  - Huang, Terry T-K
AU  - Ismail, Mona H
AU  - Kautz, Achim
AU  - Sarin, Shiv Kumar
AU  - Loomba, Rohit
AU  - Miller, Veronica
AU  - Newsome, Philip N
AU  - Ninburg, Michael
AU  - Ocama, Ponsiano
AU  - Ratziu, Vlad
AU  - Rinella, Mary
AU  - Romero, Diana
AU  - Romero-Gómez, Manuel
AU  - Schattenberg, Jörn M
AU  - Tsochatzis, Emmanuel A
AU  - Valenti, Luca
AU  - Wong, Vincent Wai-Sun
AU  - Yilmaz, Yusuf
AU  - Younossi, Zobair M
AU  - Zelber-Sagi, Shira
AU  - NAFLD Consensus Consortium
PY  - 2021
DO  - 10.1038/s41575-021-00523-4
UR  - http://hdl.handle.net/10668/19566
T2  - Nature reviews. Gastroenterology & hepatology
AB  - Non-alcoholic fatty liver disease (NAFLD) is a potentially serious liver disease that affects approximately one-quarter of the global adult population, causing a substantial burden of ill health with wide-ranging social and economic implications. It...
LA  - en
KW  - Humans
KW  - Non-alcoholic Fatty Liver Disease
TI  - Advancing the global public health agenda for NAFLD: a consensus statement.
TY  - research article
VL  - 19
ER  -